Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.65, demonstrating a -4.12% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.26%.

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...

Explaining the policies and processes that define our journalism. “The Times’s primary responsibility is to give readers accurate information, and our readers trust us to do that. By acknowledging our ...

We may never know why Samsung’s battery manufacturing partners made a handful of critical errors that led dozens of (the once widely-praised) Galaxy Note7 smartphones to overheat, and/or burst into ...